Mark Andrew Sherman sold $775k of DLB
EVP, Gen. Counsel & Secretary at Dolby Laboratories, Inc.. 11,600 shares at an average of $66.85, traded Dec 16, 2025, filed Dec 17, 2025.
Score components
- +15RoleOfficer
- +22Trade size$775k at market
- +5Share of holdings soldSold 14% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-323425, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 15, 2025 | AGrant or award Class A Common Stock10b5-1 | +25,633 | $0.00 | $0 | 88,030 | Dec 17, 2025 |
| Dec 15, 2025 | MOption exercise Class A Common Stock10b5-1 | +5,915 | $0.00 | $0 | 93,945 | Dec 17, 2025 |
| Dec 15, 2025 | FTax withholding Class A Common Stock10b5-1 | -9,252 | $67.54 | $625k | 84,693 | Dec 17, 2025 |
| Dec 16, 2025 | FTax withholding Class A Common Stock10b5-1 | -2,530 | $66.62 | $169k | 82,163 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -6,738 | $66.58 | $449k | 75,425 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -2,371 | $67.17 | $159k | 73,054 | Dec 17, 2025 |
| Dec 17, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -2,491 | $67.26 | $168k | 70,563 | Dec 17, 2025 |
| Dec 15, 2025 | AGrant or award Performance-Based Restricted Stock Unitderivative10b5-1 | +12,816 | $0.00 | $0 | 12,816 | Dec 17, 2025 |
| Dec 15, 2025 | AGrant or award Employee Stock Option (Right to Buy)derivative10b5-1 | +56,440 | $0.00 | $0 | 56,440 | Dec 17, 2025 |
| Dec 15, 2025 | MOption exercise Performance-Based Restricted Stock Unitderivative10b5-1 | -5,915 | $0.00 | $0 | 0 | Dec 17, 2025 |
Related signals
Other insiders at Dolby Laboratories, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $451k 7,667 shares | -4% | |
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $468k 7,667 shares | -6% | |
| 27Weak | Dolby Laboratories, Inc. | Ryan Nicholson VP, CAO and Corp. Controller | $177k 2,667 shares | -7% | |
| 15Weak | Dolby Laboratories, Inc. | Shriram Revankar SVP, Advanced Technology Group | $198k 3,000 shares | -3% | |
| 40Moderate | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $433k 6,667 shares | -5% | |
| 40Moderate | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.2M 33,517 shares | -25% | |
| 28Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $500k 7,273 shares | -6% | |
| 40Moderate | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.3M 34,367 shares | -26% | |
| 9Weak | Dolby Laboratories, Inc. | Mark Andrew Sherman EVP, Gen. Counsel & Secretary | $304k 4,500 shares | -7% | |
| 32Weak | Dolby Laboratories, Inc. | Tony A Prophet director | $224k 3,300 shares | -27% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.